Page 38 - Anjali Singh

Aston Martin to double its volume with new South India dealership

Aston Martin's decision to expand its footprint in South India reflects a strategic choice, due to the region's growth in the sports car segment

Electric vehicle market set to be on full charge by 2025: ICRA report

The report highlights that the electric twowheeler (e2W) segment has emerged as a frontrunner, accounting for 85-90 per cent of total EV sales in FY23

Healthcare and pharma sector sees surge in high-value deals: Report

The Private Equity (PE) sector experienced a decline in both values and volumes compared to the previous quarter

SPARC completes enrollment in PROSEEK Global Phase 2 study of Parkinson's

PROSEEK, one of the largest phase-2 studies in early Parkinson's disease, encompassed 84 sites across the United States, Europe, and India

Sun Pharma and Zydus Lifesciences partner to market kidney drug Desidustat

Under this licensing agreement, Zydus has granted Sun Pharma semi-exclusive rights to co-market Desidustat in India

Piramal Pharma clocks 11% revenue growth in quarter ending September

Company's Ebitda grows 44% year-on-year, Chairperson Nandini Piramal anticipates a stronger financial performance in H2

Valvoline targets double-digit market share growth in India over 5 years

The company is striving to establish a comprehensive ecosystem for its customers, offering a full spectrum of products, including lubricants, grease, diesel exhaust fuel, and more

DCGI approves MSD India's drug KEYTRUDA for breast cancer in adult patients

Renal cell carcinoma (RCC), the most common type of kidney cancer, predominantly affects men and has limited treatment options, often leaving patients at risk of recurrence

Torrent Pharma Q2 results: Profit after tax up 24% to Rs 386 crore

The company exhibited a 2.66 per cent increase in revenue and was able to turn around the PAT by 2.09 per cent

Breast cancer strikes younger Indian women at an alarming rate: Study

A striking 25 per cent of breast cancer cases among Indian women occurred at the age of 39 years or younger

Supriya Life targets 1-2% global mkt share with oral cancer detection kit

Quickblue is designed to detect oral cancer swiftly, eliminating the need for extensive preclinical and clinical trials

Deep discounts on offer to light up car sales in India before Diwali

Average October discounts are up 40-50% compared to last year

Glenmark Life Sciences Q2 results: PAT rises 11%, revenue up 16.9%

Generic API revenues increased by 19.7 percent this quarter due to growth in US, LATAM and Europe regulated markets

Himadri Speciality Chemical reports 5.1% revenue decline in Q2FY24

Operating in both domestic and international markets, Himadri Speciality Chemical exports to 49 countries worldwide

Glenmark gets USFDA nod to market generic version of Otezla tablets

Glenmark's current portfolio includes a total of 188 products that have been authorised for distribution in the US marketplace

Zydus appoints Punit Patel as President & CEO for North American Operations

Punit Patel brings over 20 years of experience in both generic and branded pharmaceutical sectors

Ichnos Sciences, Astria Therapeutics sign licensing deal for OX40 portfolio

Ichnos is set to receive $320 million upfront for development, regulatory and sales payments, coupled with low double-digit royalties

Excess vaccine-making capacity may get utilised in 3-5 years: Merck Life

Some 40-50 firms in India are getting into mRNA technology, says Aditya Sharma, senior executive of the German company

Mental health: Women opt for teleconsultations, while men prefer in-person

According to the WHO, India bears a significant mental health burden of 2,443 disability-adjusted life years (DALYs) per 100,000 population

Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada

Under the agreement's terms, Biocon will be responsible for obtaining regulatory approvals for Liraglutide and will subsequently manage the manufacturing and distribution of the product within Canada